Skip to content
healthcare.dev

Azacitidine

NDC 0781-3491, Azacitidine, injection, powder, lyophilized, for solution, from Sandoz Inc.

Product NDC
0781-3491
Status
Listed
Labeler
Sandoz Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212580
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3491 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZACITIDINE100 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
0781-3491-94007813491941 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0781-3491-94)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f89fcbd-d3f4-4112-8733-69baea41255e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0781-3491

Use it

Look up 0781-3491 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3491 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0781-3491. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.